Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Summit Therapeutics is a US-based biopharmaceutical company specializing in the clinical development of innovative oncology therapies. The company focuses on researching and delivering novel drugs for solid tumors, particularly for patients with non-small cell lung cancer, to improve their treatment options.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Summit Therapeutics is scheduled to report its next quarterly earnings on 11/11/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Summit Therapeutics last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at -0.28 USD.
Across its last 3 earnings reports, Summit Therapeutics stock moved by ±9.9% on average the following day. The largest reaction was -24.9% on 04/30/2026; 1 of 3 reactions were positive.
Summit Therapeutics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.